Cleared Traditional

K181781 - DynaClipTM Bone Staple

K181781 is the FDA 510(k) clearance for DynaClipTM Bone Staple by MedShape, Inc.. It is a Class 2 Orthopedic device (product code JDR) cleared through the Traditional 510(k) pathway after a 125-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
125d
Days
Class 2
Risk

K181781 is an FDA 510(k) clearance for the DynaClipTM Bone Staple. Classified as Staple, Fixation, Bone (product code JDR), Class II - Special Controls.

Submitted by MedShape, Inc. (Atlanta, US). The FDA issued a Cleared decision on November 5, 2018 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3030 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all MedShape, Inc. devices

Submission Details

510(k) Number K181781 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2018
Decision Date November 05, 2018
Days to Decision 125 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 122d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JDR Staple, Fixation, Bone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3030
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - JDR Staple, Fixation, Bone

All 99
Devices cleared under the same product code (JDR) and FDA review panel - the closest regulatory comparables to K181781.
TriMed Nitinol Staple System
K190166 · TriMed, Inc. · Jul 2019
VERTEX Nitinol Staple System
K182943 · Nvision Biomedical Technologies, LLC · Apr 2019
Geo Staple System
K182212 · Gramercy Extremity Orthopedics, LLC · Jan 2019
DynaBridge
K181815 · Fusion Orthopedics, LLC · Oct 2018
MotoCLIP/HiMAX Step Staple Implant System
K181866 · Crossroads Extremity Systems, LLC · Aug 2018
DePuy Synthes Static Staples
K180544 · Synthes USA Products, LLC · Jul 2018